Clinical indicators of treatment-resistant psychosis

Metacognitive Therapy in Treatment-Resistant Psychosis

Background: More effective psychological treatments for psychosis are required. Case series data and pilot trials suggest metacognitive therapy (MCT) is a promising treatment for anxiety and depression. Other research has found negative metacognitive beliefs and thought-control strategies may be involved in the development and maintenance of hallucinations and delusions. The potential of MCT in...

Metacognitive Therapy in Treatment-Resistant Psychosis

High-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis.

Sir: Olanzapine is a thienobenzodiazepine antipsychotic that has a broad in vitro affinity for several receptors, including serotonergic, cholinergic, dopaminergic, and adrenergic receptors. Olanzapine is approved for treatment of psychoses at doses up to 20 mg/day. New research suggests benefits of higher doses of olanzapine. Anecdotal case reports highlight the benefits of olanzapine at 50 mg...

Prognostic indicators in psychosis and neurosis.

Neurotic and psychotic patients who had been temporarily retired from naval service were reevaluated periodically and rated on degrees of disability by physical evaluation boards. Personal history and symptom variables were correlated with changes in amount of psychiatric disability over a S-yr. period. Recovery or improvement was more rapid and complete in neurotics, but improvement was more p...

etiology, significance, diagnosis and treatment of bruxiam

چکیده ندارد.